Results 181 to 190 of about 15,262 (192)

N-glycan shielded CUB domains of ADAMTS13 prevent binding of C-terminal antibodies in patients with immune-mediated TTP. [PDF]

open access: yesBlood Adv
Postmus T   +9 more
europepmc   +1 more source

Challenges in managing iTTP: insights into ADAMTS13 inhibitor boosting during caplacizumab therapy. [PDF]

open access: yesAnn Hematol
Tanaka H   +9 more
europepmc   +1 more source

Thrombotic Thrombocytopenic Purpura and Evans Syndrome: Validating and Exploring 20 Years of Routine Hospital Care. [PDF]

open access: yesJ Blood Med
Lawrie DA   +15 more
europepmc   +1 more source

Hemolytic uremic syndrome with Mycoplasma pneumoniae infection and membrane cofactor protein mutation [PDF]

open access: yes, 2016
Csuka, Dorottya   +5 more
core  

Immune-coagulation dynamics in severe COVID-19 revealed by autoantibody profiling and multi-omics integration. [PDF]

open access: yesSci Rep
Ambikan AT   +8 more
europepmc   +1 more source

Relationship Between COVID-19 and Retinal Vein Occlusions. [PDF]

open access: yesJ Ophthalmol
Muto T, Machida S, Imaizumi S, Kamoi K.
europepmc   +1 more source

Home - About - Disclaimer - Privacy